ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹46 Cr | ₹-1.95 Cr | ₹-117 Cr | ₹-131 Cr | ₹69 Cr |
What is the latest Consolidated Net Profit of ORCHID PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹46 Cr |
Mar2023 | ₹-1.95 Cr |
Mar2022 | ₹-117 Cr |
Mar2021 | ₹-131 Cr |
Mar2020 | ₹69 Cr |
How is Consolidated Net Profit of ORCHID PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹46 Cr | Positive | |
Mar2023 | ₹-1.95 Cr | Negative | |
Mar2022 | ₹-117 Cr | Negative | |
Mar2021 | ₹-131 Cr | Negative | |
Mar2020 | ₹69 Cr | - |
Compare Consolidated Net Profit of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹7,389.5 Cr | 3.1% | -22.4% | 76.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | 3.1% |
-22.4% |
76.6% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses